Thousands of state-licensed cannabis operators pursue federal registration after the historic Schedule III rescheduling by the administration.

Federal scrutiny evolves as 900+ medical cannabis dispensaries secure official registrations, paving the way for a new era in cannabis regulation.

Delving into Liberty Cannabis' history, retail operations, and customer education approach across its diverse market presence in the U.S.

Voters in Massachusetts and Idaho face cannabis ballot measures as national advocates unite to defend state-level legalization amid a critical midterm election.

A deep dive into cannabis delivery’s evolving business model, market impact, DMV opportunities, and investment outlook as highlighted by October 2026 industry developments.

Federal charges target a Virginia state legislator over alleged cannabis sales at a hemp storefront, raising big questions for operators and consumers navigating changing marijuana delivery laws in 2026.

Both major candidates for Wisconsin governor say they support some form of marijuana legalization, but differ on how fast—and how far—the reforms should go.

Oklahoma's cannabis industry faces regulatory fatigue as lawmakers urge a pause on new rules. How might this approach affect medical marijuana businesses and patients—and what lessons can the DMV take?

Over 60 legislators urge voters to reject the upcoming ballot measure that could shut down legal marijuana sales and impact the state’s regulated cannabis market.

A new state audit reveals critical flaws in Colorado’s marijuana product testing system, exposing risks for consumers and lessons for DMV cannabis delivery compliance.

Illinois set a new cannabis sales record in July 2026 after doubling purchase limits, with more affordable prices and broader access impacting revenue and consumers.

A Dutch court has declared Bedrocan Nederland B.V. and Bedrocan International B.V. bankrupt, impacting medical cannabis access and reshaping business models in the EU. DMV entrepreneurs must watch for regulatory shifts and new delivery opportunities.

The FDA outlines its ibogaine trial vision, Compass Pathways reveals pricing and slow rollout plans, and early healthcare leaders weigh in—here’s what DMV readers need to know.

New polls show 74% of North Carolina voters back medical cannabis, while 63% favor adult-use legalization, signaling major shifts in local and regional cannabis policy discussions.

Massachusetts and Idaho lead contrasting 2026 ballot initiatives that could reshape state retail markets and constitutional legalization limits.

High Times sits down with Wiz Khalifa to discuss the role of cannabis, his Khalifa Kush strain, fitness transformation, and why he left alcohol behind.

Multi-state operator Vext Science links an Ohio dispensary shutdown to a Vapen vape cartridge while state lab tests reveal no contaminants.

Nebraska regulators debate new licensing fees, transport rules, and Schedule I labeling updates as medical marijuana implementation pushes into 2027.

Federal rescheduling fuels cannabis M&A, but integration—not deal size—decides who thrives. What this shift means for Virginia, DC, and Maryland weed delivery laws.

State regulators from Colorado, Massachusetts, Maryland, and Minnesota discuss persistent gaps in cannabis reform and how new federal changes may—and may not—affect local weed delivery laws.